Drugs / CureXcell®
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT02130310 | May 2014 → May 2016 | ulcer of lower limbs | Macrocure Ltd. | Unknown | No outcome recorded |
| Phase 3 | NCT01421966 | Aug 2011 → Feb 2015 | ulcer of lower limbs | Macrocure Ltd. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CureXcell | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01421966 ↗ |
| Modality | Cell therapy | “CureXcell® is a cell based therapy” NCT01421966 ↗ |
| Route | Other | “CureXcell® injection will be administered about every 4 weeks for up to 4 treatments, or until until ulcer closure, whichever occurs first.” NCT01421966 ↗ |